Announcement on the Holding Subsidiary's Obtaining of the "Drug GMP Certificate"
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2019-034
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement
for the authenticity, accuracy and completeness of its contents.
Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company") holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical")
received the "Drug GMP Certificate" issued by Zhejiang Food and Drug Administration. The relevant information is hereby announced as follows:
1. GMPCertification Related Information
Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.Address: No. 58
Certificate No.: ZJ20190116
Certification Scope: powder injection (including cephalosporins) and freeze-dried powder injection
certification date: 2019
10 31
valid: 202410 30
2. GMPCertificate Involving Production Line
| Production Line Name |
Design Annual Capacity |
Main Variety |
| Powder Injection Production Line |
about 2000 |
cefmenoxime hydrochloride for injection, cefoxitin sodium for injection |
| freeze-dried powder injection production line |
about 1000 |
penciclovir for injection, for injection ribavirin |
| Drug Name |
Dosage Form |
Therapeutic Field |
Manufacturer |
| Injection Cefmenoxime Hydrochloride |
Powder Injection (Including Cephalosporins) |
Anti-infection |
Shanghai Shangyao Xinya Pharmaceutical Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd., Hainan Tianhuang Pharmaceutical Co., Ltd., Hainan Lingkang Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical Co., Ltd. and other 10 . |
| Injection Cefoxitin Sodium |
Powder Injection (Including Cephalosporins) |
Anti-infection |
Harbin Pharmaceutical Group Pharmaceutical General Factory, Guangdong Bozhou Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd. and Jianfeng Pharmaceutical Co., etc. 49 home. |
| Penciclovir for Injection |
Freeze-dried Powder Injection |
Antivirus |
Ruiyang Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical . |
Ribavirin for Injection |
Freeze-dried Powder Injection |
Antivirus |
Shanghai Shangyao Xinya Pharmaceutical Co., Ltd., Zhejiang Asia Pacific Pharmaceutical Co., Ltd., Haikou Qili Pharmaceutical Co., Ltd., Hainan General Kangli Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical Co., Ltd. 209 7 . |
, "Major Manufacturers " information in the above table mainly comes from the website of china food and drug administration;
4. Impact on Listed Companies and Risk TipsThe "GMP
Certificate" obtained by Jianfeng Pharmaceutical Co., Ltd. this time is that its original GMP certificate for powder injection and freeze-dried powder injection production line expires and obtains the certificate after re-certification. Re-obtaining the GMP certificate will help ensure the production capacity of the above-mentioned products and ensure the continuity of market supply. It will not have a significant impact on the Company's current operations. The future sales of various drugs of
Company may be affected by the market environment, industry policies, supply and demand and other factors, with certain uncertainties. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
November 6
, 2019
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page